Results 251 to 260 of about 3,110,681 (290)
Some of the next articles are maybe not open access.

Menopausal Hormone Therapy

Journal of Obstetrics and Gynaecology Canada, 2005
Although estrogen has been clinically available for more than 6 decades, women have been confused by different opinions regarding the risks and benefits of menopausal hormone therapy (HT), estrogen therapy (ET), and estrogen-progestin therapy (EPT).
Bhagu R, Bhavnani, Ronald C, Strickler
openaire   +2 more sources

Hormone Therapy: Gender-Affirming Hormone Therapy.

FP essentials, 2023
Approximately 0.6% of adults (1 to 1.4 million adults) in the United States identify as transgender, and 2% of high school-aged individuals (150,000 to 300,000 individuals). Gender-affirming care for transgender and gender- diverse patients can include support with social transition or physical presentation, legal steps, and medical treatments (eg ...
openaire   +1 more source

HORMONAL THERAPY IN DERMATOLOGY

Dermatologic Clinics, 2001
Hormonal therapy in dermatology is used primarily to reverse or diminish the effect of androgens, which are responsible for causing acne, hirsutism, and androgenetic alopecia. Although hormonal therapy is one of many treatments for acne, it is the only medical therapy available for hirsutism, and likely the only hope for the successful medical ...
openaire   +2 more sources

Growth hormone therapy

Best Practice & Research Clinical Endocrinology & Metabolism, 2002
Since 1958 growth hormone (GH) has been used as substitution treatment for children with GH deficiency. At present, it is clear that a dose of 0.23 mg/kg/week can lead to a final height close to target height, but in view of the wide inter-individual variation, alternative regimens based on invidualizing the dosage with the help of prediction models ...
openaire   +2 more sources

Skin and Hormone Therapy

Clinical Obstetrics and Gynecology, 2004
Glenda K, Hall, Tania J, Phillips
openaire   +2 more sources

Hormone Therapy in Menopause

2020
As longevity expands, women are spending a third of their existence in menopause and beyond. The vast majority suffer from symptoms that negatively impact their quality of life. Systemic vasomotor symptoms (VMS) are the classic cluster affecting 80% of peri- and post-menopausal women.
openaire   +2 more sources

Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?

Circulation, 2023
Chrisandra Shufelt   +2 more
exaly  

Hormone Therapy

AJN, American Journal of Nursing, 2011
openaire   +2 more sources

Menopausal Hormone Therapy

JAMA, 2019
Jan L, Shifren   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy